Disruption or innovation: Which digital front door strategy is right for your patients?

The digital front door has come to represent a logical strategy for many healthcare organizations embarking on digital transformation efforts. But will your front door be disrupted before it has even opened?

April 20, 2022 | 1:00PM ET

Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company (“Lilly”,NYSE: LLY) today announced that in light of both parties’ shared commitment to continue bringing innovative medicines […]

Disruption or innovation: Which digital front door strategy is right for your patients?

Innovent and Lilly Expand Strategic Partnership in Oncology

Tealium for Healthcare Builds Digital Trust with Patients and Physicians

Volta Medical, GE HealthCare partner on AI-driven electrophysiology tech

Regard Raises $61M to close the Clinical Insights Gap in Healthcare with leading AI solution

AI-powered automation platform for healthcare launches out of stealth with $3 million backing

NHS prepares clinicians for AI-powered COPD diagnosis

Click TO Unsubscribe

Useful Link

Email Subscriber

Click To Data Request

Subscribe to our newsletter

You May Like

Click TO Unsubscribe

Useful Link

Email Subscriber

Social Media Icons

Click To Data Request

Subscribe to our newsletter